found that the presence of a mutation in SRSF2, SF3B1, U2AF1, ZRSR2, ASXL1, EZH2, BCOR, or STAG2 was >95% specific for the diagnosis of secondary AML [5]. Here, ASXL1 is linked to acute myeloid leukemia.